Advanced tools are being deployed by Duke Health and others in the fight against vision loss. STORY HIGHLIGHTS Half of ...

Many eye conditions can be easily treated if those at risk undergo regular eye examinations, and are informed about good ...

Bausch + Lomb announced the acquisition of the ELIOS system, a laser-based technology that offers a new approach to treating ...

Global Glaucoma Therapeutics Market Poised for Growth; Set to Reach US$7.2 Billion by 2030 Glaucoma Therapeutics Market ...

Kitombe, the western lowland gorilla known by zoo staff as "Kit," was 38 years old when he died Thursday evening at the zoo.

Glaucoma is a leading cause of global blindness. Intraocular pressure (IOP) remains the only clinically-validated and ...

Nocturnal intraocular pressure (IOP) profiling has shown that the peak IOP usually occurs at night, particularly in patients with glaucoma. Multiple studies have demonstrated that these ...

The global glaucoma treatment market is projected to grow from USD 5.7 billion in 2022 to USD 8.0 billion by 2033, at a CAGR ...

Medically reviewed by Johnstone M. Kim, MD There are many types of eye diseases, all of which can cause symptoms that affect ...

Fate Therapeutics, Inc. (NASDAQ:FATE) recently reported positive data from its phase 1 autoimmunity study using FT819 for the treatment of patients with moderate-to-severe Systemic Lupus ...

In contrast, those who sold put options on the stock during the decline not only earned income through premiums but also positioned themselves to buy Tesla shares at significantly discounted prices.